MedPath

The effect of selegiline on function in stroke patients

Phase 2
Recruiting
Conditions
Stroke.
Brain stem stroke syndrome
G46.3
Registration Number
IRCT20200719048136N1
Lead Sponsor
Shahre-kord University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

primery or hemoragic ischemia
brain stroke

Exclusion Criteria

progressive brain stoke
brain tumor
subdural hematoma
multiple sclorosis
Multi-infarct dementia
epilepsy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cognitive function. Timepoint: Two weeks after the intervention. Method of measurement: Neurologic examination.
Secondary Outcome Measures
NameTimeMethod
Motor function. Timepoint: Two weeks after the intervention. Method of measurement: Neurologic examination.
© Copyright 2025. All Rights Reserved by MedPath